Aug. 10, 2006 – Micell Technologies announced an expansion of its license agreement for using supercritical fluids for creating medical device surface modifications with Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle.
Under the expansion of the agreement, research will focus on additional applications of the e-RESS technology for creating drug-eluting coatings for cardiovascular stents.
The e-RESS (e for electrostatic, RESS for Rapid Expansion from Supercritical Solution) innovation involves electrostatic capture and deposition of micro and nanoparticles onto the surface of a medical device using supercritical fluids. The e-RESS technology has been exclusively licensed to Micell from PNNL, and all product developed through this expanded agreement will be licensed to Micell under the terms of the current agreement.